Invesco Ltd. Purchases 12,489 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Invesco Ltd. boosted its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 12.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 113,153 shares of the medical instruments supplier's stock after buying an additional 12,489 shares during the quarter. Invesco Ltd. owned about 0.46% of ICU Medical worth $17,558,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Barclays PLC boosted its stake in shares of ICU Medical by 15.6% during the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock worth $10,790,000 after acquiring an additional 8,010 shares in the last quarter. Franklin Resources Inc. boosted its position in ICU Medical by 99.3% during the third quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock worth $2,111,000 after purchasing an additional 5,834 shares during the period. Principal Financial Group Inc. grew its holdings in ICU Medical by 24.6% during the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock valued at $23,130,000 after purchasing an additional 25,031 shares during the last quarter. Diversified Trust Co grew its holdings in ICU Medical by 32.3% during the fourth quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier's stock valued at $512,000 after purchasing an additional 805 shares during the last quarter. Finally, Inspire Investing LLC raised its position in shares of ICU Medical by 13.2% in the fourth quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier's stock valued at $404,000 after purchasing an additional 303 shares during the period. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Stock Performance

Shares of NASDAQ:ICUI traded down $2.00 on Friday, hitting $135.17. 38,332 shares of the company were exchanged, compared to its average volume of 272,256. The company's 50 day moving average price is $144.37 and its two-hundred day moving average price is $158.53. The firm has a market capitalization of $3.31 billion, a price-to-earnings ratio of -29.58 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a one year low of $93.36 and a one year high of $196.26.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. KeyCorp lowered their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research note on Monday. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. StockNews.com cut ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Finally, Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, ICU Medical presently has an average rating of "Moderate Buy" and a consensus price target of $162.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.